Stay updated with breaking news from Previously Approved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rising Utilization of ProSense in the U.S. Market Generates Year-over-Year Consumable Revenue Growth Physician Adoption Continues to Grow Ahead of the FDA's...
IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023 - read this article along with other careers information, tips and advice on BioSpace
Full Year 2022 Revenues of $631.5 Million; Fourth Quarter 2022 Revenues of $183.1 MillionAdjusted Operating Income Margin of 13.8% for the Full Year 2022 and 9.2% for the Fourth Quarter 2022; GAAP Operating
We hope you all had a joyous holiday season! We can't wait to see what 2023 will bring. Happy New year!
This blog addresses two decisions that must be made prior to December 29, 2022 by regional centers approved and in good standing as of the effective date of the EB-5 Reform and Integrity Act ("RIA") that do not intend to sponsor any new projects or any new investors.